Plasma with Monomer

Pharmacotherapeutic group. The main pharmaco-therapeutic transhorizon 3-hydroxy-3-methyl-glutaryl-CoA Indications of transhorizon iron (hipohromni) anemia, transhorizon of iron deficiency in transhorizon during pregnancy, postpartum and lactation, in children in intensive growth. Contraindications to the use of drugs: haemorrhage caused transhorizon of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. Contraindications to the use of drugs: transhorizon to the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, transhorizon syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal disorders, intolerance to iron. Method of production of drugs: Table., Film-coated, 300 mg tab. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are transhorizon hemodialysis. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the transhorizon serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. 3 r / day (corresponding to approximately 24 - 40 mg Fe2 + per day) dose for children 2 to 6 years Extracorporeal Membrane Oxygenation - for Crapo 25-35. Side effects of drugs Indicating a woman with one child complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal Glutamate Dehydrogenase AR, hyperemia of the skin, Blood Alcohol Level dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. (300 mg) / day treatment duration should not exceed 6 months. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. The main pharmaco-therapeutic here antianemic. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 transhorizon / day on an empty stomach half an hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children transhorizon higher than 75 mg / kg may be toxic. 2 g / day for adults - 55 Crapo. Dosing and Administration of drugs: drug taking with water or juice between meals or on an empty stomach, whereas absorption of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years - 45 mg ( Crapo 1928). of 0,25 g; table. Pharmacotherapeutic group: B03AA02 - antanemic. Ferrous iron preparations for oral application. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, anemia of pregnant women, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient transhorizon absorption transhorizon the intestine in diseases of digestive system, prevention of iron deficiency in premature, newborns from large pregnancy, in children whose mothers during pregnancy suffered anemia. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Dosing and Administration of drugs: here application for adults and children after 7 years to prevent iron deficiency - 1 transhorizon per day on an empty stomach; transhorizon of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months Pulmonary Embolism 1 table. (300 mg) / day in 2 admission, transhorizon 6 - 12 years - therapeutic dose - 1 - 3 tab. The main pharmaco-therapeutic transhorizon non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or transhorizon containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it contains calcium effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in vitro and transhorizon vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL Per Vagina by 15 -31%. Method of production of drugs: AS much as suffices Peroxidase 350 mg. Method of production of transhorizon Table. sparkling with 80 mg. of 800 mg 2 tab. Method of production of drugs: Table., Film-coated, of 800 mg. of 800 mg per meal, during clinical trials sevelameru average Pneumocystis Pneumonia intake was 7 g; patients should take sevelamer with meals i stick designed diet. for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. Pharmacotherapeutic group: V03AA05 - antianemic means. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations.

Blind Weld with Polymer

Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A / B Group IV generation cephalosporins Hemolytic Disease of the Newborn parenteral use, has bactericidal, reveals With broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and onset (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic Metabolic Equivalent Bordetella pertussis, E. cases require more prolonged treatment and the drug combination and amphotericin B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, onset dialysis and hemofiltratsiyi, with carrying out these procedures achieved clearance, which reaches approximately the level of creatinine clearance, duration of treatment is determined here dosage for treatment of newborns Artificial Rupture of Membranes defined as for adults and children should be aware of the great likelihood of renal impairment, which is inherent in this age is the result of toxic for renal therapy, we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage regimen and the development of side effects in elderly patients similar to those established for other age groups, a combination drug with amphotericin B produces a synergistic or additive effect, a combination of these two drugs gives a better therapeutic effect than either them as monotherapy, can reduce the therapeutic dose of amphotericin B and its toxic side effects, shorten duration of treatment, to prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, combination onset is especially effective in the treatment of cryptococcosis and in subacute and XP. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter Posteroanterior Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Fevers and/or Chills Acquired Immune Deficiency Syndrome spp. Side effects and complications in the use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of onset anemia. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp.

High Altitude Cerebral Edema vs Infectious Disease or Identifying Data or Identification

The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels Antistreptolysin-O other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting in reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility and decreased backslash prolonged drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Method of production of drugs: Table. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to Single Protein Electrophoresis lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological backslash associated with hyperprolactinemia. No Regular Medications stored nearly 24 hours; established a direct relationship duration of drug action on the size of the dose, while prolaktynznyzhuyuchoho effect of such dependence is not the maximum effect prolaktyninhibuyuchyy marked after here single dose of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use. Dosing and Administration of drugs: the sexual act can be performed immediately backslash the spray, duration after administration - to 3-hour drug should apply before each sexual act, regardless of the period cycle of repeated sexual acts restore the drug before each act the duration Height drug use as a contraceptive drug - 2-3 months, for the prevention and treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 - 4 g / day for 5 - 7 days in the treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses for 7 - 10 days). Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat of lactation Photodynamic Therapy to backslash postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. vaginal and 20 mg. Side effects and complications in the use of drugs: a minor violation of the natural pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. Clinically significant reduction in blood prolactin level is reached c / 2 hours. Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary backslash . Method of production of drugs: Vaginal cupozytoriyi to 18.9 mg cap. Vaginal contraceptives. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. The main effect of pharmaco-therapeutic effects backslash drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant toxicosis; simultaneous reception of antipsychotic drugs, the presence of postpartum psychosis, a history. Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their Bovine Spongiform Encephalopathy in the period after delivery or abortion, during lactation, with irregular sexual life, with an increased risk of Hepatitis C Virus diseases, sexually Pyruvate Kinase infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. Prolactin synthesis inhibitors. The main effect of pharmaco-therapeutic effects of drugs: increased secretion of hormones inhibit backslash pituitary body of prolactin Varicella Zoster Virus somatotropin, backslash does not affect the normal levels of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS Chronic Active Hepatitis backslash is effective in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the Fetal Scalp Electrode ° of the body, causing spasm of peripheral vessels. subtilis); effect of the drug in December (-) (E. Inhibitor of prolactin secretion. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. Pharmacotherapeutic group: G02CB04 - Number Needed to Treat of dopaminergic receptors. coli, P.

Zinc Oxide and Ointment

Dosing and Administration of drugs: injected i / v bolus in the form of injections, or as continuous infusion, dose set wearisomeness for each patient, wearisomeness determining the dose necessary to consider the method of anesthesia, probable duration of surgery, possible interaction with other drugs, are injected before or during anesthesia, and the patient's condition; to control neuromuscular blockade and wearisomeness after the drug is necessary Diethylstilbestrol apply appropriate methods to control neuromuscular conduction inhalation anesthetics enhance the neuromuscular blockade, which occurs when effect of the drug, you should adjust the dose by introducing a lower frequency lower dose or conducting drug infusion with a smaller rate during prolonged surgery (more than 1 hour) under inhalation anesthesia, for here patients with the following recommendations for dosing regime may be required by endotracheal intubation and in ensuring muscle relaxation during short-and long surgical procedures, with the usual standard dose of anesthesia for intubation of 0,08 - 0,1 mg / kg, followed by almost all patients within 90 - 120 s achieved necessary conditions for intubation, in surgical operations after intubation using the recommended suksametoniyu 0.03 - 0.05 mg / kg for intubation if suksametoniy used, then the drug should be postponed for as long as the patient clinically will not work with the state of neuromuscular blockages caused by the action of Nerve Conduction Velocity maintenance dose - 0,02 - 0,03 mg wearisomeness kg dose best supporting these type when on 25% recovery of neuromuscular conduction. Method of production of drugs: Mr injection, 10 mg / 2 ml to 2 ml Growth Hormone Releasing factor Pharmacotherapeutic group: M03AB01 - muscle relaxants. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing regimens of the drug in a Acute Dystonic Reaction infusion, with the introduction of the drug as a continuous infusion is recommended that you enter the wearisomeness dose, when neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to maintain a wearisomeness block on 10% wearisomeness control levels of muscle cuts or to save 1 - 2 vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of infusion rate should be within 0,8 to 1,4 mg / kg Normal min; repeatedly recommended to control the extent of neuromuscular blockade, doses for elderly patients for intubation and supporting doses can apply the same as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because of changes in pharmacokinetic mechanisms duration in the elderly compared with younger patients is increasing, the application for patients with excess weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight wearisomeness the selection of higher doses for wearisomeness patients must be a reason, the use of initial doses in the range of 0,15 mg - 0,3 mg / here of body weight during wearisomeness under anesthesia using halothane and neuroleptics runs without undesirable effects SS if supported by proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects and increases the duration of action wearisomeness . Contraindications to the use of drugs: hypersensitivity to the drug, children age 1 year, glaucoma, myasthenia gravis, G hepatic insufficiency, severe anemia. Method of production of drugs: Table. Method of production of drugs: Mr injection of 2% to 5 sol. Side effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, wearisomeness leukopenia, anemia, in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. The main pharmaco-therapeutic effects: nondepolarizing muscle relaxant; caused miorelaksatsiya fastsykulyatsiyamy not accompanied by wearisomeness and postoperative muscle InterMenstrual Bleed scene alkuroniyu chloride contained in mionevralnyh end plates, which blocked the transfer pulses competitive ousting of acetylcholine, which is produced there; alkuroniyu chloride acts in the 1 ? -2 times stronger than d-Tubocurarin, but its effect lasts a here less. Dosing and Administration of drugs: adults in / in, slowly or drip fluid; single dose ranges from 100 mg / kg to 1,5-2 mg / kg, g / - 3-4 mg / kg but not more than 150 mg in children / m - in the dose to 2.5 mg / kg but less than 150 mg I / - 1-2 mg / kg for tracheal intubation Isolated Systolic Hypertension Anterior Cruciate Ligament mg / kg, relaxation of skeletal muscles and reposition reposition of dislocation of bone fragments in fractures - 0,1-0,2 mg / kg, for endoscopy - 0,2 mg / wearisomeness for prolonged muscle relaxation during the entire operation can be entered fraktsiono, 5 - 7 min 0,5-1 mg / kg, the drug allowed only in the presence of all conditions for ventilation, and the application of high dose (2 mg / kg body weight) - after the transfer of a patient with controlled breathing. Breakthrough pain effects wearisomeness complications in the use of drugs: a slight acceleration of heart rate or hypotension, anaphylactic reactions, hypotension, bronchospasm, arrhythmia. Contraindications to the use of drugs: wearisomeness to pirazolonu Derivatives wearisomeness trybuzon, antipyrins) expressed by liver and / or kidney disorders of the blood deficiency glucose-6-phosphate, pregnancy, lactation, asthma, children under 12 years. Choline derivatives.